Dawaa Reference

Clinical reference

Vocal Cord Polyp

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class RD99.06 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care · Vestibular Schwannoma - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK562312/

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (REFERRAL & ADVICE)

1st line
Adult dose and duration

A benign growth on the vocal cord, often from voice overuse or smoking, causing persistent hoarseness; managed with voice rest, speech therapy, and ENT referral for microlaryngoscopy and removal if it does not improve, since there is no drug treatment. - Refer, with advice

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

A benign growth on the vocal cord, often from voice overuse or smoking, causing persistent hoarseness; managed with voice rest, speech therapy, and ENT referral for microlaryngoscopy and removal if it does not improve, since there is no drug treatment.

Cautions
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Hoarseness persisting beyond three weeks, especially in a smoker, needs ENT assessment to exclude laryngeal cancer.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.